Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in a Tertiary Hospital from the Comunidad Valenciana (Spain)
Por:
Sánchez-Serrano A, García-González N, Bonillo D, Ruiz-Hueso P, Villanova R, Campo-Bes I, Tormo N, Salvador C, Gimeno C and González-Candelas F
Publicada:
1 dic 2022
Ahead of Print:
1 oct 2022
Resumen:
To reduce the high rates of morbidity and mortality caused by methicillin-resistant Staphylococcus aureus (MRSA) strains, it is essential to prevent their transmission. This can be achieved through molecular surveillance of the infecting strains, for which the detection of the entry of new strains, the analysis of antimicrobial resistance, and their containment are essential. In this study, we have analyzed 190 MRSA isolates obtained at the Consorcio Hospital General Universitario de Valencia (Spain) from 2013 to 2018 with three approaches: Multilocus Sequence Typing, spa, and SCCmec typing. Although the incidence of S. aureus infections detected in the hospital increased in the study period, the frequency of MRSA isolates decreased from 33% to 18%. One hundred seventy-two MRSA isolates were resistant to three or more classes of antimicrobials, especially to fluoroquinolones. No relevant temporal trend in the distribution of antibiotic susceptibility was observed. The combination of the three typing schemes allowed the identification of 74 different clones, of which the combination ST125-t067-IV was the most abundant in the study (27 cases). Members of three clonal complexes, CC5, CC8, and CC22, comprised 91% of the isolates, and included 32 STs and 32 spa types. The emergence of low incidence strains throughout the study period and a large number of isolates resistant to different classes of antibiotics shows the need for epidemiological surveillance of this pathogen. Our study demonstrates that epidemiological and molecular surveillance is a powerful tool to detect the emergence of clinically important MRSA clones.
Filiaciones:
:
Joint Research Unit Infection and Public Health FISABIO-University Valencia, Institute for Integrative Systems Biology I2SysBio (CSIC-UV), Valencia, Spain
:
Joint Research Unit Infection and Public Health FISABIO-University Valencia, Institute for Integrative Systems Biology I2SysBio (CSIC-UV), Valencia, Spain
:
Joint Research Unit Infection and Public Health FISABIO-University Valencia, Institute for Integrative Systems Biology I2SysBio (CSIC-UV), Valencia, Spain
:
Joint Research Unit Infection and Public Health FISABIO-University Valencia, Institute for Integrative Systems Biology I2SysBio (CSIC-UV), Valencia, Spain
:
Joint Research Unit Infection and Public Health FISABIO-University Valencia, Institute for Integrative Systems Biology I2SysBio (CSIC-UV), Valencia, Spain
:
Joint Research Unit Infection and Public Health FISABIO-University Valencia, Institute for Integrative Systems Biology I2SysBio (CSIC-UV), Valencia, Spain
Tormo N:
Microbiology Department, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
Salvador C:
Microbiology Department, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
Gimeno C:
Microbiology Department, Consorcio Hospital General Universitario de Valencia, Valencia, Spain
:
Joint Research Unit Infection and Public Health FISABIO-University Valencia, Institute for Integrative Systems Biology I2SysBio (CSIC-UV), Valencia, Spain
CIBER in Epidemiology and Public Health, Valencia, Spain
|